YS Biopharma Co., Ltd.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has YS Biopharma Co., Ltd.'s balance sheet done over the years? Its assets were worth $1,719,753,611 last year, which is more than in the previous period. 58% of YS Biopharma Co., Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $991,300,326, which means an decrease by -54% compared compared to last year.
Debt to Assets
| 2021 | 1167175072 | 1.67B | 143.6% |
|---|---|---|---|
| 2022 | 1441753141 | 2.14B | 148.48% |
| 2023 | 1719753611 | 991.30M | 57.64% |
YS Balance Sheet (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Assets | |||
Current assets: | |||
Cash and cash equivalents | 370.10M | 271.06M | 390.45M |
Short term investments | 0 | 0 | 0 |
Net receivables | 463.05M | 308.55M | 248.12M |
Inventory | 185.38M | 166.50M | 81.43M |
Other current assets | 17.43M | 7.98M | 74.51K |
Total current assets | 1.03B | 764.76M | 733.20M |
Non-current assets: | |||
Property, Plant and Equipment | 582.88M | 565.00M | 253.45M |
Goodwill | 0 | 0 | 0 |
Intangible assets | 78.05M | 80.71M | 83.77M |
Long term investments | 0 | 0 | 0 |
Other non-current assets | 20.92M | 28.22M | 88.76M |
Total non-current assets | 683.77M | 676.98M | 433.97M |
Total assets | 1.71B | 1.44B | 1.16B |
Liabilities | |||
| Current liabilities: | |||
Accounts payable | |||
Deferred revenue | 2.29M | 2.29M | 2.12M |
Short term debt | 198.49M | 116.05M | 3.78M |
Total current liabilities | 658.76M | 475.91M | 345.04M |
| Non-current liabilities: | |||
Long term debt | 300.13M | 264.53M | 14.65M |
Deferred tax | 0 | 0 | 0 |
Other non-current liabilities | 8.79M | 1.37B | 1.28B |
Total non-current liabilities | 332.53M | 1.66B | 1.33B |
Total liabilities | 991.30M | 2.14B | 1.67B |
| Data source |